Information and communication in the context of a clinical trial

P Hietanen, A R Aro, K Holli, P Absetz

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Udgivelsesdato: 2000-Oct
OriginalsprogEngelsk
TidsskriftEuropean Journal of Cancer
Vol/bind36
Udgave nummer16
Sider (fra-til)2096-2104
Antal sider8
ISSN0959-8049
StatusUdgivet - 1. okt. 2000

Fingeraftryk

Communication
Clinical Trials
Patient Education

Citer dette

Hietanen, P., Aro, A. R., Holli, K., & Absetz, P. (2000). Information and communication in the context of a clinical trial. European Journal of Cancer, 36(16), 2096-2104.
Hietanen, P ; Aro, A R ; Holli, K ; Absetz, P. / Information and communication in the context of a clinical trial. I: European Journal of Cancer. 2000 ; Bind 36, Nr. 16. s. 2096-2104.
@article{820f66a00f1911deb27a000ea68e967b,
title = "Information and communication in the context of a clinical trial",
abstract = "The aim of this study was to determine the communicative needs of the patients in the context of being invited to participate in a clinical trial. A questionnaire was sent to 299 patients with breast cancer randomised in a trial of adjuvant therapy. It was returned by 261 (87{\%}) of them. Ninety-one per cent (231/255) of the patients regarded the information provided as easy or quite easy to understand. However, the method of treatment allocation was unclear to most patients: 51{\%} (128/251) thought that the doctor had chosen the treatment while only 23{\%} (57/251) knew that they had been randomised. Younger and better educated patients had a better understanding. For 55{\%} (125/226) of the patients written information had been helpful in decision making. This correlated highly with the education of the patient. Sixty-eight per cent (174/255) of the patients thought that they had enough time for decision-making. Less educated patients and older patients had needed more time. Eighty-seven per cent (218/251) were happy with their decision to participate. While most patients are satisfied with the information received, there is a poor understanding of how treatment is allocated. Information should be modified for older and less-educated patients. The needs of the patients when offered participation in a clinical trial are clear information, enough time to consider the options and psychological support.",
keywords = "Adult, Aged, Awareness, Breast Neoplasms, Chemotherapy, Adjuvant, Communication, Decision Making, Female, Follow-Up Studies, Humans, Middle Aged, Patient Education as Topic, Patient Participation, Patient Satisfaction, Physician-Patient Relations, Questionnaires, Randomized Controlled Trials as Topic",
author = "P Hietanen and Aro, {A R} and K Holli and P Absetz",
year = "2000",
month = "10",
day = "1",
language = "English",
volume = "36",
pages = "2096--2104",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Pergamon",
number = "16",

}

Hietanen, P, Aro, AR, Holli, K & Absetz, P 2000, 'Information and communication in the context of a clinical trial', European Journal of Cancer, bind 36, nr. 16, s. 2096-2104.

Information and communication in the context of a clinical trial. / Hietanen, P; Aro, A R; Holli, K; Absetz, P.

I: European Journal of Cancer, Bind 36, Nr. 16, 01.10.2000, s. 2096-2104.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Information and communication in the context of a clinical trial

AU - Hietanen, P

AU - Aro, A R

AU - Holli, K

AU - Absetz, P

PY - 2000/10/1

Y1 - 2000/10/1

N2 - The aim of this study was to determine the communicative needs of the patients in the context of being invited to participate in a clinical trial. A questionnaire was sent to 299 patients with breast cancer randomised in a trial of adjuvant therapy. It was returned by 261 (87%) of them. Ninety-one per cent (231/255) of the patients regarded the information provided as easy or quite easy to understand. However, the method of treatment allocation was unclear to most patients: 51% (128/251) thought that the doctor had chosen the treatment while only 23% (57/251) knew that they had been randomised. Younger and better educated patients had a better understanding. For 55% (125/226) of the patients written information had been helpful in decision making. This correlated highly with the education of the patient. Sixty-eight per cent (174/255) of the patients thought that they had enough time for decision-making. Less educated patients and older patients had needed more time. Eighty-seven per cent (218/251) were happy with their decision to participate. While most patients are satisfied with the information received, there is a poor understanding of how treatment is allocated. Information should be modified for older and less-educated patients. The needs of the patients when offered participation in a clinical trial are clear information, enough time to consider the options and psychological support.

AB - The aim of this study was to determine the communicative needs of the patients in the context of being invited to participate in a clinical trial. A questionnaire was sent to 299 patients with breast cancer randomised in a trial of adjuvant therapy. It was returned by 261 (87%) of them. Ninety-one per cent (231/255) of the patients regarded the information provided as easy or quite easy to understand. However, the method of treatment allocation was unclear to most patients: 51% (128/251) thought that the doctor had chosen the treatment while only 23% (57/251) knew that they had been randomised. Younger and better educated patients had a better understanding. For 55% (125/226) of the patients written information had been helpful in decision making. This correlated highly with the education of the patient. Sixty-eight per cent (174/255) of the patients thought that they had enough time for decision-making. Less educated patients and older patients had needed more time. Eighty-seven per cent (218/251) were happy with their decision to participate. While most patients are satisfied with the information received, there is a poor understanding of how treatment is allocated. Information should be modified for older and less-educated patients. The needs of the patients when offered participation in a clinical trial are clear information, enough time to consider the options and psychological support.

KW - Adult

KW - Aged

KW - Awareness

KW - Breast Neoplasms

KW - Chemotherapy, Adjuvant

KW - Communication

KW - Decision Making

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Middle Aged

KW - Patient Education as Topic

KW - Patient Participation

KW - Patient Satisfaction

KW - Physician-Patient Relations

KW - Questionnaires

KW - Randomized Controlled Trials as Topic

M3 - Journal article

C2 - 11044647

VL - 36

SP - 2096

EP - 2104

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 16

ER -